NO994135L - Kinoksalindioner - Google Patents

Kinoksalindioner

Info

Publication number
NO994135L
NO994135L NO994135A NO994135A NO994135L NO 994135 L NO994135 L NO 994135L NO 994135 A NO994135 A NO 994135A NO 994135 A NO994135 A NO 994135A NO 994135 L NO994135 L NO 994135L
Authority
NO
Norway
Prior art keywords
preparation
quinoxalinediones
solvate
compounds
processes
Prior art date
Application number
NO994135A
Other languages
English (en)
Norwegian (no)
Other versions
NO994135D0 (no
Inventor
Alan Stobie
Elisabeth Colette Loui Gautier
David Charles Waite
Robert James Crook
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000995 external-priority patent/WO1997032873A1/en
Priority claimed from GBGB9715783.8A external-priority patent/GB9715783D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO994135D0 publication Critical patent/NO994135D0/no
Publication of NO994135L publication Critical patent/NO994135L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO994135A 1997-02-27 1999-08-26 Kinoksalindioner NO994135L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP1997/000995 WO1997032873A1 (en) 1996-03-09 1997-02-27 Quinoxalinediones
GBGB9715783.8A GB9715783D0 (en) 1997-02-27 1997-07-25 Quinoxalinediones
PCT/EP1998/001275 WO1998038186A1 (en) 1997-02-27 1998-02-24 Quinoxalinediones

Publications (2)

Publication Number Publication Date
NO994135D0 NO994135D0 (no) 1999-08-26
NO994135L true NO994135L (no) 1999-10-22

Family

ID=26070194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994135A NO994135L (no) 1997-02-27 1999-08-26 Kinoksalindioner

Country Status (16)

Country Link
EP (1) EP0973766B1 (de)
JP (2) JP3588363B2 (de)
CN (2) CN1121403C (de)
AT (1) ATE282608T1 (de)
BG (1) BG103685A (de)
BR (1) BR9808126A (de)
CA (1) CA2281580C (de)
DE (1) DE69827614T2 (de)
ES (1) ES2230685T3 (de)
HR (1) HRP980104A2 (de)
HU (1) HUP0003612A3 (de)
NO (1) NO994135L (de)
NZ (1) NZ336842A (de)
SK (1) SK113399A3 (de)
TR (1) TR199902055T2 (de)
WO (1) WO1998038186A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones
GB0310881D0 (en) * 2003-05-12 2003-06-18 Merck Sharp & Dohme Pharmaceutical formulation
MY145368A (en) * 2004-01-13 2012-01-31 Nissan Chemical Ind Ltd Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
EP1713101B1 (de) 2004-02-06 2012-10-31 Yamaguchi University Elektrode für eine energiespeichereinrichtung und herstellungsprozess dafür
JP2009539846A (ja) * 2006-06-06 2009-11-19 ブリストル−ミエルス スクイッブ カンパニー Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形
CN104370834B (zh) 2007-05-17 2017-04-19 株式会社半导体能源研究所 三唑衍生物
WO2011051478A1 (en) * 2009-10-30 2011-05-05 Domain Therapeutics Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221425B (en) * 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones

Also Published As

Publication number Publication date
DE69827614D1 (de) 2004-12-23
BG103685A (bg) 2000-06-30
CA2281580A1 (en) 1998-09-03
WO1998038186A1 (en) 1998-09-03
NZ336842A (en) 2000-05-26
EP0973766B1 (de) 2004-11-17
HUP0003612A2 (hu) 2001-10-28
DE69827614T2 (de) 2005-11-10
SK113399A3 (en) 2001-04-09
CN1443763A (zh) 2003-09-24
ATE282608T1 (de) 2004-12-15
EP0973766A1 (de) 2000-01-26
JP3588363B2 (ja) 2004-11-10
BR9808126A (pt) 2000-03-08
CN1248971A (zh) 2000-03-29
JP2004269547A (ja) 2004-09-30
HUP0003612A3 (en) 2003-04-28
HRP980104A2 (en) 1999-02-28
ES2230685T3 (es) 2005-05-01
CN1121403C (zh) 2003-09-17
TR199902055T2 (xx) 2000-07-21
NO994135D0 (no) 1999-08-26
CA2281580C (en) 2003-04-22
JP2000509730A (ja) 2000-08-02

Similar Documents

Publication Publication Date Title
YU41199A (sh) Hinoksalindioni
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
ATE297203T1 (de) Antithrombotische mitteln
DE69831868D1 (en) Antithrombosemittel
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
EA199900373A2 (ru) Фармацевтические композиции
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
DE69932173D1 (de) Adenine-derivate
AU2003228770A1 (en) Substituted pyrazolopyrimidines
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
SE0202483D0 (sv) Chemical compounds
BG105539A (bg) Елетриптан хидробромид монохидрат
DE69827614D1 (de) Chinoxalindionen
DE60201074D1 (en) Pyrazolopyridinderivate
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
SE9904128D0 (sv) Novel compounds
MY129094A (en) Condensed polycyclic compounds
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
EA199900688A1 (ru) Хиноксалиндионы
YU82302A (sh) Derivati 2-aminokarbonil-9h-purina
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
AU1783700A (en) 1,8-benzonaphthyridine derivatives